Technical Analysis for MRTX - Mirati Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 73.19 -4.06% -3.10
MRTX closed down 4.06 percent on Tuesday, March 19, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MRTX trend table...

Date Alert Name Type % Chg
Mar 19 MACD Bearish Signal Line Cross Bearish 0.00%
Mar 19 20 DMA Support Bullish 0.00%
Mar 19 Slingshot Bullish Bullish Swing Setup 0.00%
Mar 18 Shooting Star Candlestick Bearish -4.06%
Mar 18 MACD Bullish Signal Line Cross Bullish -4.06%
Mar 18 Doji - Bearish? Reversal -4.06%
Mar 18 New 52 Week High Strength -4.06%
Mar 18 Upper Bollinger Band Touch Strength -4.06%
Mar 15 180 Bullish Setup Bullish Swing Setup -4.09%
Mar 15 Earnings Movers Other -4.09%

Older signals for MRTX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Mirati Therapeutics Inc., a biopharmaceutical company, engages in the development of therapeutics for the cancer treatment. Its lead program in clinical development is MGCD265, a multi-targeted small molecule kinase inhibitor for treatment of oncology patients with solid tumors. The company also evaluates development opportunities in oncology for mocetinostat, a spectrum-selective HDAC inhibitor for the treatment of patients with myelodysplastic syndrome or lymphoma; and MGCD516, a kinase inhibitor with a target profile for the treatment of patients with non-small cell lung cancer and other solid tumors. Mirati Therapeutics Inc. is headquartered in San Diego, California.
Medicine Biopharmaceutical Cancer Chemical Compounds Solid Tumors Oncology Non Small Cell Lung Cancer Lymphoma Cancer Treatment Targeted Therapy Myelodysplastic Syndrome Bemcentinib
Is MRTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 80.0
52 Week Low 24.65
Average Volume 745,489
200-Day Moving Average 52.8058
50-Day Moving Average 68.4136
20-Day Moving Average 73.188
10-Day Moving Average 71.779
Average True Range 3.9153
ADX 32.95
+DI 27.8215
-DI 18.6919
Chandelier Exit (Long, 3 ATRs ) 68.2541
Chandelier Exit (Short, 3 ATRs ) 76.7959
Upper Bollinger Band 79.7692
Lower Bollinger Band 66.6068
Percent B (%b) 0.5
BandWidth 17.984369
MACD Line 1.7446
MACD Signal Line 1.8524
MACD Histogram -0.1078
Fundamentals Value
Market Cap 1.83 Billion
Num Shares 25 Million
EPS -3.38
Price-to-Earnings (P/E) Ratio -21.65
Price-to-Sales 0.00
Price-to-Book 3.81
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 80.63
Resistance 3 (R3) 81.06 79.00 79.39
Resistance 2 (R2) 79.00 77.11 78.79 78.98
Resistance 1 (R1) 76.10 75.94 75.07 75.67 78.56
Pivot Point 74.04 74.04 73.53 73.83 74.04
Support 1 (S1) 71.14 72.15 70.11 70.71 67.82
Support 2 (S2) 69.08 70.98 68.87 67.40
Support 3 (S3) 66.18 69.08 66.99
Support 4 (S4) 65.75